Stem Cell Research & Therapy, 2019 · DOI: https://doi.org/10.1186/s13287-019-1491-7 · Published: December 1, 2019
Spinal cord injury is a severe neurological condition, and mesenchymal stem cells (MSCs) show promise for regenerative medicine. This study investigates the effect of hMSC-conditioned medium supplemented with bFGF, EGF, and patient plasma, named neural regeneration laboratory medium (NRLM), on SCI in vitro and in vivo. Compared to standard culture medium, NRLM-CM had superior inflammation reduction and neurite regeneration effects in vitro and improved functional restoration in SCI rats in vivo.
The NRLM culture system can be used for the large-scale production of functionally competent MSCs for clinical applications in SCI treatment.
The superior neural repair function of conditioned medium derived from NRLM-expanded MSCs highlights its therapeutic potential.
NRLM provides a means to rapidly expand MSCs, even from older donors, which can reduce manufacturing time and accelerate MSC production.